Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vistagen Therapeutics (VTGN) Non-cash Items (2021 - 2023)

Vistagen Therapeutics' Non-cash Items history spans 2 years, with the latest figure at $10.7 million for Q1 2021.

  • For Q1 2021, Non-cash Items changed N/A year-over-year to $10.7 million; the TTM value through Mar 2021 reached $10.7 million, changed N/A, while the annual FY2021 figure was $10.7 million, N/A changed from the prior year.
  • Non-cash Items for Q1 2021 was $10.7 million at Vistagen Therapeutics, up from $4.2 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $10.7 million in Q1 2021 and bottomed at $10.7 million in Q1 2021.